DWT
TAK icon

Dorsey & Whitney Trust’s Takeda Pharmaceutical TAK Stock Holding History

Dorsey & Whitney Trust’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Sell
18,110
-355
-2% -$5.87K 0.01% 602
2026
Q1 		$342K Buy
18,465
+881
+5% +$15.5K 0.02% 523
2025
Q4 		$274K Buy
17,584
+2,153
+14% +$30.8K 0.01% 588
2025
Q3 		$226K Sell
15,431
-466
-3% -$6.92K 0.01% 621
2025
Q2 		$246K Sell
15,897
-4,243
-21% -$62.7K 0.01% 590
2025
Q1 		$299K Buy
20,140
+4,591
+30% +$64.3K 0.02% 515
2024
Q4 		$206K Sell
15,549
-773
-5% -$10.6K 0.01% 639
2024
Q3 		$232K Buy
16,322
+452
+3% +$6.41K 0.01% 602
2024
Q2 		$205K Sell
15,870
-2,327
-13% -$30.8K 0.01% 591
2024
Q1 		$253K Buy
18,197
+798
+5% +$11.6K 0.02% 529
2023
Q4 		$248K Sell
17,399
-10,422
-37% -$148K 0.02% 508
2023
Q3 		$430K Buy
27,821
+8,406
+43% +$130K 0.04% 342
2023
Q2 		$305K Sell
19,415
-1,833
-9% -$30K 0.03% 432
2023
Q1 		$350K Buy
21,248
+8,304
+64% +$132K 0.03% 395
2022
Q4 		$202K Sell
12,944
-12,041
-48% -$168K 0.02% 530
2022
Q3 		$324K Buy
24,985
+13,671
+121% +$190K 0.03% 381
2022
Q2 		$158K Sell
11,314
-9,110
-45% -$130K 0.02% 514
2022
Q1 		$293K Buy
20,424
+3,086
+18% +$45.3K 0.03% 426
2021
Q4 		$237K Sell
17,338
-62
-0.4% -$870 0.02% 482
2021
Q3 		$285K Buy
17,400
+1,670
+11% +$28K 0.03% 411
2021
Q2 		$265K Sell
15,730
-1,343
-8% -$22.9K 0.03% 430
2021
Q1 		$312K Buy
17,073
+2,341
+16% +$42.1K 0.03% 379
2020
Q4 		$268K Sell
14,732
-1,720
-10% -$30.2K 0.03% 379
2020
Q3 		$294K Buy
16,452
+1,842
+13% +$33.5K 0.04% 304
2020
Q2 		$262K Buy
+14,610
New +$262K 0.04% 337

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Dorsey & Whitney Trust's TAK Position: Q2 2026 in Review

Dorsey & Whitney Trust reduced its Takeda Pharmaceutical (TAK) stake by 1.9% in Q2 2026, selling an estimated $5.87K and leaving 18,110 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #602.

Dorsey & Whitney Trust first reported a position in TAK in Q2 2020 and has held it in 25 quarters since. The position peaked at $430K in Q3 2023. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Dorsey & Whitney Trust held 18,110 shares of Takeda Pharmaceutical worth $290K as of Q2 2026.
  • Dorsey & Whitney Trust sold 355 Takeda Pharmaceutical shares in Q2 2026, an estimated $5.87K.
  • Takeda Pharmaceutical made up 0.01% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #602 holding.
  • Dorsey & Whitney Trust first reported a position in Takeda Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
  • Dorsey & Whitney Trust's Takeda Pharmaceutical position peaked at $430K in Q3 2023.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.